According to a new report, published by KBV research, The Global Magnetoencephalography Market size is expected to reach $350.1 million by 2028, rising at a market growth of 5.1% CAGR during the forecast period.
The Clinical market is leading the segment in the Global Magnetoencephalography Market by Application in 2021; thereby, achieving a market value of $196.1 million by 2028. This is because of the rising incidence of neurodegenerative diseases in the general population. When used in clinical contexts, MEG produces accurate diagnostic findings with an extraordinarily high spatial and temporal resolution, which are usually superior to those produced by other methods when used in clinical settings.
The Hospitals market is showcasing a CAGR of 4.6 % during the forecast period. This is relevant to a large patient pool and hospitals' increased acceptance of technically sophisticated MEG scanners. In the years to come, the development of the category is projected to be driven by growing levels of competition and demand for healthcare services of world-class caliber.
The North America market dominated the Global Magnetoencephalography Market by Region in 2021; thereby, achieving a market value of $122.2 million by 2028. The Europe market is anticipated to grow at a CAGR of 4.9% during (2022 - 2028). Additionally, The Asia Pacific market would witness a CAGR of 5.6% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/magnetoencephalography-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Compumedics Limited, Ricoh Company, Ltd, FieldLine, Inc., MEGIN OY, CTF MEG Neuro Innovations, Inc. and Cerca Magnetics Limited
By Application
By End-use
By Geography
Companies Profiled
Unique Offerings 
